BeOne Medicines Ltd. (SHA:688235)
China
· Delayed Price · Currency is CNY 230.20
+2.10 (0.92%)
May 30, 2025, 3:00 PM CST
BeOne Medicines Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -4,706 | -6,252 | -13,821 | -9,261 | -10,609 |
| Depreciation & Amortization | 1,219 | 595.18 | 434.89 | 288.99 | 207.54 |
| Other Amortization | 34.52 | 26.51 | 22.24 | 6.13 | - |
| Asset Writedown & Restructuring Costs | -96.54 | -60.23 | -191.31 | -184.14 | -29.29 |
| Loss (Gain) From Sale of Investments | 175.34 | 115.02 | 151.71 | -48.48 | -77.21 |
| Stock-Based Compensation | 3,223 | 2,607 | 2,091 | 1,529 | 1,198 |
| Other Operating Activities | 271.13 | -2,611 | 76.6 | 170.8 | -52.42 |
| Change in Accounts Receivable | -2,405 | -1,335 | 2,098 | -2,687 | 67.66 |
| Change in Inventory | -667.84 | -999.45 | -391 | -974.06 | -384.57 |
| Change in Accounts Payable | 886.82 | 152.34 | -30.02 | 127.1 | 625.67 |
| Change in Unearned Revenue | 4.62 | -1,812 | -1,047 | 2,590 | - |
| Change in Other Net Operating Assets | 1,034 | 1,367 | 283.72 | 192.46 | 674.35 |
| Operating Cash Flow | -1,026 | -8,207 | -10,322 | -8,250 | -8,379 |
| Capital Expenditures | -3,596 | -3,984 | -2,245 | -1,670 | -767.16 |
| Sale (Purchase) of Intangibles | -266.23 | -243.68 | -990.89 | -329.76 | -714.88 |
| Investment in Securities | -119.35 | 4,668 | 10,675 | 6,070 | -19,190 |
| Other Investing Activities | -20.89 | -14.71 | -10.24 | - | -13.22 |
| Investing Cash Flow | -4,002 | 425.48 | 7,429 | 4,070 | -20,685 |
| Short-Term Debt Issued | 6,338 | 4,691 | 2,164 | 2,582 | 2,113 |
| Long-Term Debt Issued | 66.08 | 159.56 | 257.76 | 106.97 | 719.5 |
| Total Debt Issued | 6,404 | 4,850 | 2,422 | 2,689 | 2,833 |
| Short-Term Debt Repaid | -5,140 | -2,195 | -2,877 | -2,044 | -79.96 |
| Long-Term Debt Repaid | -204.6 | -97.07 | - | - | -862.17 |
| Total Debt Repaid | -5,345 | -2,292 | -2,877 | -2,044 | -942.13 |
| Net Debt Issued (Repaid) | 1,059 | 2,558 | -454.77 | 645 | 1,891 |
| Issuance of Common Stock | 331.18 | 395.05 | 323.92 | 22,459 | 28,237 |
| Other Financing Activities | 21.9 | - | - | - | 3,840 |
| Financing Cash Flow | 1,412 | 2,953 | -130.85 | 23,104 | 33,967 |
| Foreign Exchange Rate Adjustments | -377.4 | -57.31 | -478.55 | 89.16 | 119.02 |
| Net Cash Flow | -3,994 | -4,886 | -3,503 | 19,013 | 5,022 |
| Free Cash Flow | -4,622 | -12,192 | -12,567 | -9,921 | -9,146 |
| Free Cash Flow Margin | -16.62% | -69.93% | -128.68% | -132.76% | -453.57% |
| Free Cash Flow Per Share | -43.90 | -116.79 | -121.85 | -106.92 | -109.57 |
| Cash Interest Paid | 373.53 | 140.07 | 173.6 | 190.37 | 288.11 |
| Cash Income Tax Paid | 506.78 | 397.11 | 203.47 | 99.7 | 69.18 |
| Levered Free Cash Flow | -2,679 | -9,034 | -6,509 | -7,648 | -4,911 |
| Unlevered Free Cash Flow | -2,612 | -9,015 | -6,426 | -7,536 | -4,838 |
| Change in Net Working Capital | 631.9 | 2,660 | -1,976 | 1,648 | -2,003 |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.